Fig. 5From: Extracellular vesicles remodel tumor environment for cancer immunotherapySchematic representation of engineered EVs implementing immunotherapy in a mouse model. After intravenous injection, engineered EVs carrying therapeutic molecules are targeted to the tumour site, followed by the release of immunotherapy-related drugs into the TMEBack to article page